March 14, 2024 — The American Medical Association (AMA) has issued a new letter to federal officials in which it praised the creation of the Change Healthcare/Optum Payment Disruption (CHOPD) Accelerated Payments as “helpful for physician p
March 13, 2024 — In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.
March 13, 2024 — Two nationally recognized cardiovascular programs, New Jersey-based Atlantic Health System’s Morristown Medical Center and New York-based NYU Langone Health, have announced that they are expanding their partnership to provide patients improved access to adult congenital heart
March 13, 2024 — Silence Therapeutics has announced positive topline 36-week data from the ongoing ALPACAR-360 phase 2 study of zerlasiran (SLN360) in 178 subjects with baseline lipoprotein(a), or Lp(a), levels at or over 125 nmol/L at h
March 12, 2024 — Medtronic plc, a global leader in healthcare technology, today announced two late-breaking data presentations on four-year outcomes from the Evolut Low Risk Trial.
